Large Study Finds No Link Between mRNA COVID-19 Vaccine in Pregnancy and Autism

What Did the Study Find About COVID-19 Vaccination During Pregnancy and Autism?

A large prospective study tracked more than 400 toddlers born to mothers who received mRNA COVID-19 vaccines either during pregnancy or in the period shortly before conception. Researchers conducted detailed developmental assessments, including evaluations of speech, motor skills, social behavior, and cognitive milestones, and found no statistically significant link between maternal vaccination and autism spectrum disorder or other developmental delays.

The study adds to a robust and growing evidence base supporting the safety of mRNA COVID-19 vaccines in pregnancy. Previous large-scale registry studies, including data from the CDC's V-safe surveillance system and studies from Scandinavian birth registries, have similarly shown no increased risk of adverse neurodevelopmental outcomes in children exposed to maternal COVID-19 vaccination. Health authorities including the WHO, CDC, and the American College of Obstetricians and Gynecologists (ACOG) continue to recommend COVID-19 vaccination for pregnant individuals.

Why Is This Research Important for Expectant Parents?

Vaccine hesitancy during pregnancy remains a significant public health challenge. Surveys have consistently shown that concerns about potential effects on fetal development are among the top reasons pregnant individuals decline or delay vaccination. Misinformation linking vaccines to autism — rooted in a debunked 1998 study — continues to circulate widely on social media, and the introduction of novel mRNA vaccine technology during the pandemic amplified these fears for many expectant parents.

By directly measuring neurodevelopmental outcomes in children using validated clinical assessment tools, this study provides the kind of evidence that can meaningfully reassure patients and healthcare providers. Importantly, COVID-19 infection during pregnancy has been associated with increased risks of preterm birth, preeclampsia, and other complications, making vaccination a critical tool for protecting both maternal and infant health. The researchers emphasized that the benefits of vaccination in pregnancy continue to outweigh theoretical risks, which this study found no evidence to support.

How Was the Study Conducted and What Methods Were Used?

The study employed a prospective cohort design, enrolling pregnant individuals and following their children through early toddlerhood. Developmental outcomes were assessed using standardized clinical tools designed to detect early signs of autism spectrum disorder and other neurodevelopmental conditions. These assessments covered key domains including language acquisition, social communication, fine and gross motor skills, and adaptive behavior.

The researchers compared outcomes between children whose mothers received mRNA COVID-19 vaccines (either the Pfizer-BioNTech or Moderna formulations) during pregnancy or in the periconceptional period and those whose mothers were not vaccinated during pregnancy. After adjusting for potential confounding factors, the analysis found no meaningful difference in developmental outcomes between the groups, providing strong evidence against a causal relationship between maternal mRNA vaccination and childhood autism or developmental delays.